Skip to content

Apotheek Tobback: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Tobback

BE 0832.737.575
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€273,324
2024 · €268,422+€4,901
Equity
€1.0m
2024 · €1.2m-€193,931
Cash
€424,210
2024 · €565,833-€141,624
Balance sheet total
€1.1m
2024 · €1.3m-€227,819

Largest movements

2024 to 2025
Assets
  • Cash -€141,624

    down €141,624 (-25.0%), from €565,833 to €424,210

    mainly Contributions, distributions and other (-€467,254) and Current portion of long-term debt (-€28,874)

  • Current investments -€65,196

    down €65,196 (-21.3%), from €306,000 to €240,804

  • Tangible fixed assets -€24,427

    down €24,427 (-12.4%), from €197,004 to €172,577

    of which Land and buildings: -€17,268

Equity and liabilities
  • Reserves -€193,931

    down €193,931 (-15.8%), from €1.2m to €1.0m

  • Current portion of long-term debt -€28,874

    down €28,874 (-100%), from €28,874 to €0

Income statement
  • Financial income +€5,520

    up €5,520 (+78.2%), from €7,062 to €12,582

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €268,422
Gross operating margin +€2,235
Depreciation -€356
Other operating charges +€187
Financial income +€5,520
Financial charges -€420
Taxes -€2,265
Result 2025 €273,324
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€294,911
Investment +€59,593
Financing -€496,128
Cash 2024 €565,833
Net result for the year +€273,324
Depreciation +€30,030
Stocks and contracts +€7,324
Receivables within one year -€10,148
Smaller working-capital items -€867
Trade debts -€4,452
Tax, wage and social debts +€1,627
Other debts -€1,926
Investment in fixed assets (net) -€5,603
Current investments +€65,196
Current portion of long-term debt -€28,874
Contributions, distributions and other -€467,254
Cash 2025 €424,210
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,295,370 €1,067,550 -€227,819 -17.6%
Fixed assets 21/28 €197,004 €172,577 -€24,427 -12.4%
Tangible fixed assets 22/27 €197,004 €172,577 -€24,427 -12.4%
Land and buildings 22 €157,756 €140,489 -€17,268 -10.9%
Plant, machinery and equipment 23 €30,637 €28,973 -€1,664 -5.4%
Furniture and vehicles 24 €8,611 €3,116 -€5,496 -63.8%
Current assets 29/58 €1,098,365 €894,973 -€203,392 -18.5%
Stocks and contracts in progress 3 €137,897 €130,573 -€7,324 -5.3%
Stocks 30/36 €137,897 €130,573 -€7,324 -5.3%
Amounts receivable within one year 40/41 €86,135 €96,283 +€10,148 +11.8%
Trade receivables 40 €84,952 €93,971 +€9,019 +10.6%
Other amounts receivable 41 €1,183 €2,312 +€1,129 +95.5%
Current investments 50/53 €306,000 €240,804 -€65,196 -21.3%
Cash at bank and in hand 54/58 €565,833 €424,210 -€141,624 -25.0%
Deferred charges and accrued income 490/1 €2,500 €3,103 +€603 +24.1%
Total equity and liabilities 10/49 €1,295,370 €1,067,550 -€227,819 -17.6%
Equity 10/15 €1,224,683 €1,030,753 -€193,931 -15.8%
Contributions 10/11 €400 €400 = 0.0%
Reserves 13 €1,224,283 €1,030,352 -€193,931 -15.8%
Distributable reserves 133 €1,224,283 €1,030,352 -€193,931 -15.8%
Profit (loss) carried forward 14 €0 €0 = 0.0%
Amounts payable 17/49 €70,686 €36,798 -€33,889 -47.9%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €70,364 €36,739 -€33,625 -47.8%
Current portion of amounts payable after more than one year 42 €28,874 €0 -€28,874 -100%
Trade debts 44 €37,256 €32,804 -€4,452 -12.0%
Suppliers 440/4 €37,256 €32,804 -€4,452 -12.0%
Taxes, remuneration and social security 45 €2,308 €3,936 +€1,627 +70.5%
Taxes 450/3 €2,308 €3,936 +€1,627 +70.5%
Other amounts payable 47/48 €1,926 €0 -€1,926 -100%
Accrued charges and deferred income 492/3 €322 €58 -€264 -81.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €29,674 €30,030 +€356 +1.2%
Other operating charges 640/8 €1,939 €1,751 -€187 -9.7%
Gross operating margin 9900 €415,252 €417,487 +€2,235 +0.5%
Operating profit (loss) 9901 €383,640 €385,706 +€2,066 +0.5%
Financial income 75/76B €7,062 €12,582 +€5,520 +78.2%
Recurring financial income 75 €7,062 €12,582 +€5,520 +78.2%
Financial charges 65/66B €1,914 €2,334 +€420 +22.0%
Recurring financial charges 65 €1,914 €2,334 +€420 +22.0%
Profit (loss) for the period before taxes 9903 €388,788 €395,954 +€7,166 +1.8%
Income taxes 67/77 €120,365 €122,630 +€2,265 +1.9%
Profit (loss) for the period 9904 €268,422 €273,324 +€4,901 +1.8%
Profit (loss) for the period to be appropriated 9905 €268,422 €273,324 +€4,901 +1.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.